1. Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease;Abraham;Am J Pathol,1997
2. Identification of novel targets in scleroderma, update on population studies, cDNA arrays, SNP analysis, and mutations;Ahmed;Curr Opin Rheumatol,2003
3. Intravenous cyclophosphamide therapy for systemic sclerosis. A single-center experience and review of the literature with pooled analysis of lung function test results;Airo;Clin Exp Rheumatol,2004
4. Lack of association of eNOS (G894T) and p22hox NAPDH oxidase subunit (C242T) polymorphism with systemic sclerosis in a cohort of French Caucasian patients;Allanore;Clin Chim Acta,2004
5. Detection of cellular microchimerism of male or female origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA-Cw antigens;Artlett;Arthritis Rheum,2000